These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26241816)

  • 1. Patient-reported sexual toxicity after radiation therapy in long-term prostate cancer survivors.
    Olsson CE; Alsadius D; Pettersson N; Tucker SL; Wilderäng U; Johansson KA; Steineck G
    Br J Cancer; 2015 Sep; 113(5):802-8. PubMed ID: 26241816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-reported genitourinary toxicity for long-term prostate cancer survivors treated with radiation therapy.
    Olsson CE; Pettersson N; Alsadius D; Wilderäng U; Tucker SL; Johansson KA; Steineck G
    Br J Cancer; 2013 May; 108(10):1964-70. PubMed ID: 23632483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urethral pain among prostate cancer survivors 1 to 14 years after radiation therapy.
    Pettersson N; Olsson C; Tucker SL; Alsadius D; Wilderäng U; Johansson KA; Steineck G
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e29-37. PubMed ID: 23237005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal patterns of selected late toxicities in patients treated with brachytherapy or brachytherapy plus external beam radiation for prostate adenocarcinoma.
    Buckstein M; Kerns S; Forysthe K; Stone NN; Stock RG
    BJU Int; 2013 Mar; 111(3 Pt B):E43-7. PubMed ID: 23046084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The burden of overtreatment: comparison of toxicity between single and combined modality radiation therapy among low risk prostate cancer patients.
    Jiang R; Tomaszewski JJ; Ward KC; Uzzo RG; Canter DJ
    Can J Urol; 2015 Feb; 22(1):7648-55. PubMed ID: 25694014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and Predicting Factors for Commonly Neglected Sexual Side Effects to External-Beam Radiation Therapy for Prostate Cancer.
    Frey A; Pedersen C; Lindberg H; Bisbjerg R; Sønksen J; Fode M
    J Sex Med; 2017 Apr; 14(4):558-565. PubMed ID: 28258954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favourable long-term outcomes with brachytherapy-based regimens in men ≤60 years with clinically localized prostate cancer.
    Kollmeier MA; Fidaleo A; Pei X; Cohen G; Zaider M; Mo Q; Cox B; Yamada Y; Zelefsky MJ
    BJU Int; 2013 Jun; 111(8):1231-6. PubMed ID: 23551568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome and toxicity of salvage brachytherapy for local failure after initial radiotherapy for prostate cancer.
    Burri RJ; Stone NN; Unger P; Stock RG
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1338-44. PubMed ID: 20138442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-reported gastrointestinal symptoms among long-term survivors after radiation therapy for prostate cancer.
    Alsadius D; Olsson C; Pettersson N; Tucker SL; Wilderäng U; Steineck G
    Radiother Oncol; 2014 Aug; 112(2):237-43. PubMed ID: 25201126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination external beam radiation and brachytherapy boost with androgen suppression for treatment of intermediate-risk prostate cancer: an initial report of CALGB 99809.
    Hurwitz MD; Halabi S; Ou SS; McGinnis LS; Keuttel MR; Dibiase SJ; Small EJ
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):814-9. PubMed ID: 18407435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erectile function following brachytherapy, external beam radiotherapy, or radical prostatectomy in prostate cancer patients.
    Putora PM; Engeler D; Haile SR; Graf N; Buchauer K; Schmid HP; Plasswilm L
    Strahlenther Onkol; 2016 Mar; 192(3):182-9. PubMed ID: 26713323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term potency preservation following brachytherapy for prostate cancer.
    Snyder KM; Stock RG; Buckstein M; Stone NN
    BJU Int; 2012 Jul; 110(2):221-5. PubMed ID: 22734475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Median 5 year follow-up of 125iodine brachytherapy as monotherapy in men agedGómez-Iturriaga Piña A; Crook J; Borg J; Lockwood G; Fleshner N
    Urology; 2010 Jun; 75(6):1412-6. PubMed ID: 20035986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation Dose to the Penile Structures and Patient-Reported Sexual Dysfunction in Long-Term Prostate Cancer Survivors.
    Thor M; Olsson CE; Oh JH; Alsadius D; Pettersson N; Deasy JO; Steineck G
    J Sex Med; 2015 Dec; 12(12):2388-97. PubMed ID: 26564611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of treatments for erectile dysfunction among survivors of prostate carcinoma.
    Schover LR; Fouladi RT; Warneke CL; Neese L; Klein EA; Zippe C; Kupelian PA
    Cancer; 2002 Dec; 95(11):2397-407. PubMed ID: 12436448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical outcome of intermediate risk prostate cancer treated with iodine 125 monotherapy: The Hotel-Dieu of Quebec experience].
    Zebentout O; Apardian R; Beaulieu L; Harel F; Martin AG; Vigneault E
    Cancer Radiother; 2010 Jun; 14(3):183-8. PubMed ID: 20418145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brachytherapy improves biochemical failure-free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: a propensity score matched analysis.
    Smith GD; Pickles T; Crook J; Martin AG; Vigneault E; Cury FL; Morris J; Catton C; Lukka H; Warner A; Yang Y; Rodrigues G
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):505-16. PubMed ID: 25596107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining sexual outcomes after treatment for localized prostate carcinoma.
    Schover LR; Fouladi RT; Warneke CL; Neese L; Klein EA; Zippe C; Kupelian PA
    Cancer; 2002 Oct; 95(8):1773-85. PubMed ID: 12365027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.